Kynam Capital Management, LP 13D and 13G filings for Vera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 12:15 pm Sale |
2024-09-30 | 13G | Vera Therapeutics, Inc. VERA |
Kynam Capital Management, LP | 1,576,549 2.490% |
-2,073,790 (-56.81%) |
Filing |
| 2024-02-14 12:49 pm Purchase |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Kynam Capital Management, LP | 3,650,339 8.220% |
2,241,241 (+159.06%) |
Filing |
| 2023-02-10 1:20 pm Purchase |
2022-12-30 | 13G | Vera Therapeutics, Inc. VERA |
Kynam Capital Management, LP | 1,409,098 5.100% |
1,409,098 (New Position) |
Filing |